Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice

British Journal of Cancer

Volumn 89, Issue 12, 2003, Pages 2327-2332

  Leuraud, P ^a,d   Taillandier, L ^b   Aguirre Cruz, L ^a,e   Medioni, J ^a,c   Criniere E ^a   Marie, Y ^a   Dutrillaux, A M ^d   Kujas, M ^a   Duprez, A ^b   Delattre, J Y ^a   Poupon, M F ^d   Sanson, M ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d INSTITUT CURIE   (France)

^e NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

EGFR; Oligodendroglioma; Preclinical models; Xenograft

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; TELOMERASE; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER TRANSPLANTATION; CARCINOGENIC ACTIVITY; CELL DIVISION; CENTRAL NERVOUS SYSTEM TUMOR; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENETIC CORRELATION; GENETICS; GLIOBLASTOMA; GLIOMA; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUSE; MUTATION; MUTATIONAL ANALYSIS; NONHUMAN; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE; XENOGRAFT;

ADULT; AGED; ANIMALS; CELL DIVISION; CENTRAL NERVOUS SYSTEM NEOPLASMS; FEMALE; GENES, ERBB-1; GENES, P53; GENES, TUMOR SUPPRESSOR; GLIOMA; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICE; MICE, NUDE; MIDDLE AGED; MODELS, ANIMAL; MUTATION; NEOPLASM TRANSPLANTATION; PHOSPHORIC MONOESTER HYDROLASES; PROTO-ONCOGENES; PTEN PHOSPHOHYDROLASE; TELOMERASE; TUMOR SUPPRESSOR PROTEINS;

EID: 10744221002     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601466     Document Type: Article

References (33)

1. Bigner SH, Schold SC, Friedman HS, Mark J, Bigner DD (1989) Chromosomal composition of malignant human gliomas through serial subcutaneous transplantation in athymic mice. Cancer Genet Cytogenet 40: 111-120
2. Bigner SH, Vogelstein B (1990) Cytogenetics and molecular genetics of malignant gliomas and medulloblastoma. Brain Pathol 1: 12-18
3. Bras-Goncalves RA, Pocard M, Formento JL, Poirson-Bichat F, De Pinieux G, Pandrea I, Arvelo F, Ronco G, Villa P, Coquelle A, Milano G, Lesuffleur T, Dutrillaux B, Poupon MF (2001) Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis. Gastroenterology 120: 874-888
4. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90: 1473-1479
5. Daumas-Duport C, Tucker ML, Kolles H, Cervera P, Beuvon F, Varlet P, Udo N, Koziak M, Chodkiewicz JP (1997) Oligodendrogliomas. Part II: a new grading system based on morphological and imaging criteria. J Neurooncol 34: 61-78
6. de Pinieux G, Legrier ME, Poirson-Bichat F, Courty Y, Bras-Goncalves R, Dutrillaux AM, Nemati F, Oudard S, Lidereau R, Broqua P, Junien JL, Dutrillaux B, Poupon MF (2001) Clinical and experimental progression of a new model of human prostate cancer and therapeutic approach. Am J Pathol 159: 753-764
7. Ding H, Shannon P, Lau N, Wu X, Roncari L, Baldwin RL, Takebayashi H, Nagy A, Gutmann DH, Guha A (2003) Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model. Cancer Res 63: 1106-1113
8. European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products (1999) Note for guidance on the pre-clinical evaluation of anticancer medicinal products (www.eudra. org/emea)
9. EORTC Laboratory Research Division (2001) European Organization for Research and Treatment of Cancer (EORTC) Laboratory Research Division workshop on the role of in vivo pre-clinical models in the development of contemporary cancer therapeutics, Verona, Italy, 3 February 2001. Eur J Cancer 37: 1976-1980
10. Goike HM, Asplund AC, Pettersson EH, Liu L, Sanoudou D, Collins VP (1999) Acquired rearrangement of an amplified epidermal growth factor receptor (EGFR) gene in a human glioblastoma xenograft. J Neuropathol Exp Neurol 58: 697-701
11. Hamelin R, Laurent-Puig P, Olschwang S, Jego N, Asselain B, Remvikos Y, Girodet J, Salmon RJ, Thomas G (1994) Association of p53 mutations with short survival in colorectal cancer. Gastroenterology 106: 42-48
12. He J, Mokhtari K, Sanson M, Marie Y, Kujas M, Huguet S, Leuraud P, Capelle L, Delattre JY, Poirier J, Hoang-Xuan K (2001) Glioblastomas with an oligodendroglial component: a pathological and molecular study. J Neuropathol Exp Neurol 60: 863-871
13. Humphrey PA, Wong AJ, Vogelstein B, Friedman HS, Werner MH, Bigner DD, Bigner SH (1988) Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts. Cancer Res 48: 2231-2238
14. Hunter SB, Abbott K, Varma VA, Olson JJ, Barnett DW, James CD (1995) Reliability of differential PCR for the detection of EGFR and MDM2 gene amplification in DNA extracted from FFPE glioma tissue. J Neuropathol Exp Neurol 54: 57-64
15. Ino Y, Betensky RA, Zlatescu MC, Sasaki H, Macdonald DR, Stemmer-Rachamimov AO, Ramsay DA, Cairncross JG, Louis DN (2001) Molecular subtypes of anaplastic oligodendrogliomas: implications for patient management at diagnosis. Clin Cancer Res 7: 839-845
16. Jeuken JW, Sprenger SHE, Wesseling P, Bernsen AJJA, Suijkerbuijk RF, Roelofs F, Macville MVE, Gilhuis HJ, van Overbeeke JJ, Boerman RH (2000) Genetic reflection of glioblastoma biopsy material in xenografts: characterization of 11 glioblastoma xenograft lines by comparative genomic hybridization. J Neurosurg 92: 652-658
17. Kleihues P, Cavenee WK (eds) (2000) Tumors of the Central Nervous System; Pathology and Genetics: World Health Organization International Classification of Tumours. IARC Press, Lyon
18. Kolfschoten GM, Pinedo HM, Scheffer PG, Schluper HM, Erkelens CA, Boven E (2000) Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification system. Gynecol Oncol 76: 362-368
19. Krasagakis K, Almond-Roesler B, Geilen C, Fimmel S, Krengel S, Chatzaki E, Gravanis A, Orfanos CE (2001) Growth and characterization of a cell line from a human primary neuroendocrine carcinoma of the skin (Merkel cell carcinoma) in culture and as xenograft. J Cell Physiol 187: 386-391
20. Louis DN, Holland EC, Cairncross JG (2001) Glioma classification: A molecular reappraisal. Am J Pathol 159: 779-786
21. McLaurin J, Trudel GC, Shaw IT, Antel JP, Cashman NR (1995) A human glial hybrid cell line differentially expressing genes subserving oligodendrocyte and astrocyte phenotype. J Neurobiol 26: 283-293
22. Merrill JE, Matsushima K (1988) Production of and response to interleukin 1 by cloned human oligodendroglioma cell lines. J Biol Regul Homeost Agents 2: 77-86
23. Muleris M, Almeida A, Dutrillaux AM, Pruchon E, Vega F, Delattre JY, Poisson M, Malfoy B, Dutrillaux B (1994) Oncogene amplification in human gliomas: a molecular cytogenetic analysis. Oncogene 9: 2717-2722
24. Post GR, Dawson G (1992) Characterization of a cell line derived from a human oligodendroglioma. Mol Chem Neuropathol 16: 303-317
25. Poupon MF, Arvelo F, Goguel AF, Bourgeois Y, Jacrot M, Hanania N, Arriagada R, Le Chevalier T (1993) Response of small-cell lung cancer xenografts to chemotherapy: multidrug resistance and direct clinical correlates. J Natl Cancer Inst 85: 2023-2039
26. Reifenberger J, Ring GU, Gies U, Cobbers L, Oberstrass J, An HX, Niederacher D, Wechsler W, Reifenberger G (1996) Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. J Neuropathol Exp Neurol 55: 822-831
27. Rofstad EK, Wahl A, Stokke T, Nesland JM (1990a) Establishment and characterization of six human melanoma xenograft lines. APMIS 98: 945-953
28. Rofstad EK, Zaffaroni N, Hystad ME (1990b) Heterogenous radiation and heat sensitivity in vitro of human melanoma xenograft lines established from different lesion in the same patient. Int J Radiat Biol 57: 1113-1122
29. Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB (2000) Alterations of chromosome arms 1p and 10q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18: 636-645
30. von Deimling A, Louis DN, von Ammon K, Petersen I, Hoell T, Chung RY, Martuza RL, Schoenfeld DA, Yasargil MG, Wiestler OD, Seizinger BR (1992) Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J Neurosurg 77: 295-301
31. Walker DG, Duan W, Popovic EA, Kaye AH, Tomlinson FH, Lavin M (1995) Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas. Cancer Res 55: 20-23
32. Workman P, Twentyman P, Balkwill F, Balmain A, Chaplin D, Double J, Embleton J, Newell D, Raymond R, S J, Stephens T, Wallace J (1998) United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the welfare of animals in experimental neoplasia (Second edition). Br J Cancer 77: 1-10
33. Zhou XP, Li YJ, Hoang-Xuan K, Laurent-Puig P, Mokhtari K, Longy M, Sanson M, Delattre JY, Thomas G, Hamelin R (1999) Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations. Int J Cancer 84: 150-154